期刊文献+

抗人SARS病毒单链抗体库的构建 被引量:4

Construction of a large human scFv library against SARS virus
下载PDF
导出
摘要 目的:利用细胞内重组的方法,构建大库容量的人源性抗SARS病毒单链抗体(scFv)库,为筛选SARS病毒抗原的人源性抗体奠定基础。方法:取6例SARS康复患者的80mL外周血,分离淋巴细胞后提取总RNA。分离纯化mRNA并反转录成cDNA后,扩增抗体重链、轻链可变区基因片段。然后经重叠延伸PCR装配成scFv基因并克隆入噬粒载体pDAN5中,电转化大肠杆菌TG1构建初级抗体库。制备初级库噬菌体后,感染大肠杆菌BS1365进行细胞内重组制备次级抗体库。结果:初级库库容量为3×109,在大肠杆菌BS1365中重组后得到3×1011的次级抗体库。结论:细胞内重组方法的应用可使大库容量抗体库的构建变得简单易行。构建的抗SARS病毒单链抗体次库不仅接近人类天然抗体库的水平,而且多样性好,为筛选抗SARS病毒抗原的抗体提供了保证。 AIM: To construct a large human scFv library against SARS virus by using in vivo recombination. METHODS: Total RNA was isolated from the lymphocytes of 6 patients recovered from SARS. mRNA was isolated and reverse transcribed into cDNA. The V_H and V_L fragments were amplified from the cDNA and then assembled into scFv genes. The scFv genes were amplified and ligated into phagemid pDAN5. The primary library was constructed by transforming the recombinant phagemid into E.coli TG1. The secondary library was generated by in vivo recombination in E.coli BS1365 following the infection of BS1365 by primary library phages. RESULTS: A primary library of 3×10 9 and a second library of 3×10 11 were constructed. CONCLUSION: A large human scFv library against SARS virus with good diversity was constructed, which may be used for screening antibodies to SARS virus antigens.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2005年第4期449-451,455,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(No.C0302050102)
关键词 冠状病毒 单链抗体库 细胞内重组 SARS-CoV scFv library intracellular recombination
  • 相关文献

参考文献10

  • 1杨军,高天文,王刚,王雷,沈柱,李春英.黑素瘤患者噬菌体抗体库的构建与筛选[J].细胞与分子免疫学杂志,2004,20(5):588-591. 被引量:4
  • 2郭玉,廖端芳,朱炳阳,唐圣松.利用噬菌体肽库筛选抗黏附的活性多肽[J].细胞与分子免疫学杂志,2004,20(1):34-37. 被引量:2
  • 3Sblattero D, Bradbury A. A definitive set of oligonucleotide primers for amplifying human V regions [J].Immunotechnology, 1998, 3(4):271 - 278.
  • 4武婕,郑文岭,张宏斌,王捷,江悦华,黄文杰,马文丽.抗SARS-CoV抗原的人源Fab段噬菌体抗体库的构建[J].细胞与分子免疫学杂志,2004,20(5):592-594. 被引量:7
  • 5Sblattero D, Bradbury A. Exploiting recombination in single bacteria to make large phage antibody libraries[ J ]. Nat Biotechnol, 2000, 18(1): 75 -80.
  • 6Foote J, Eisen HN. Kinetic and affinity limits on antibodies produced during immune responses[J]. PNAS, 1995, 92(5) : 1254 - 1256.
  • 7梅林,李京,闫婕,刘婷婷,李学军.SARS冠状病毒编码蛋白质及其基因分析的研究进展[J].细胞与分子免疫学杂志,2004,20(1):126-128. 被引量:11
  • 8Pang H, Liu Y, Han X, et al. Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine[ J]. J Gen Virol, 2004,85(10) : 3109 -3113.
  • 9Buchholz UJ, Bukreyev A, Yang L, et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity[ J]. Proc Natl Acad Sci USA, 2004, 101 (26) :9804 - 9809.
  • 10Huang LR, Chiu CM, Yeh SH, et al. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA[J]. J Med Viro, 2004, 73(3) : 338 -346.

二级参考文献13

  • 1Aujame L, Geoffroy F, Sodoyer F, et al. High affinity human antibodies by phage display[J]. Human Antibodies, 1997, 8:155 -168.
  • 2Winter G, Griffith AD, Hawkins RE, et al. Making antibodies by phage display technology[ J]. Annu Rer Immunol, 1994,12: 433 -437.
  • 3Michael S, Susanna T, Felikss M, et al. Phage display selection on whole cells yields a peptide specific for melanocoetin receptor 1 [J]. J Biol Chem, 1997, 272: 27943 - 27948.
  • 4Roovers RC, vander Linden E, de Bruine AP, et al. Identification of colon tumor association antigens by phage antibody selections on primary colorectal carcinoma[J]. Eur J Cancer, 2001, 37 (4): 542 -549.
  • 5Li J, Pereira S, Van BP, et al. Isolation of the melanoma-associated antigen p23 using antibody phage display[J]. J Immunol, 2001,166( 1 ): 432 -438.
  • 6Pluschke G, Vanek M, Evans A, et al. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan[J]. Proc Natl Acad Sci USA, 1996, 93:9710-9715.
  • 7Machold KP, Smolen JS. Adalimumab-a new TNF-alpha antibody for treatment of inflammatory joint disease [J]. Expert Opin Biol Ther,2003, 3(2): 351 -360.
  • 8Souriau C, Hudson PJ. Recombinant antibodies for cancer diagnosis and therapy[J]. Expert Opin Biol Ther, 2003, 3(2): 305 -318.
  • 9Power B, Hudson P. Keystone Symposia: Antibody-based therapeutics for cancer[J]. Expert Opin Biol Ther, 2003, 3(2): 385 -389.
  • 10齐杰,方锐,周慧,李惟.直接用噬菌体肽进行功能性分析的研究[J].生物化学杂志,1997,13(5):576-579. 被引量:1

共引文献20

同被引文献21

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部